Senti Biosciences COO Curt A. Herberts III resigns effective August 19, 2022

Senti Biosciences, Inc.

Curt A. Herberts III notified his resignation as Chief Operating Officer on July 26, 2022.
Resignation is effective as of August 19, 2022; no reason for departure was disclosed.
No successor or interim COO has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Curt A. Herberts III

Chief Operating Officer

SNTI · Senti Biosciences, Inc.

Effective: 2022-08-19
Filed: July 29, 2022, 7:59 PM ET

On July 26, 2022, Curt A. Herberts III, the Chief Operating Officer of Senti Biosciences, Inc., a Delaware corporation (the “Company”), notified the Company of his decision to resign from his employment with the Company, effective as of August 19, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Curt A. Herberts III resigned as Chief Operating Officer at Senti Biosciences, Inc..

Action: resigned
Role: Chief Operating Officer

Exact text from the filing

On July 26, 2022, Curt A. Herberts III, the Chief Operating Officer of Senti Biosciences, Inc., a Delaware corporation (the “Company”), notified the Company of his decision to resign from his employment with the Company, effective as of August 19, 2022.

View on SEC.gov

Senti Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001854270-22-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.